# Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine

> **NCT00311727** · NA · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 339 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Influenza A/H5N1

## Key facts

- **NCT ID:** NCT00311727
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 339 (ACTUAL)
- **Last updated:** 2013-08-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00311727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00311727, "Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00311727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*